Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note released on Monday. The firm issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of NYSE RVP opened at $0.80 on Monday. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. The stock’s fifty day moving average price is $0.78 and its two-hundred day moving average price is $0.76. Retractable Technologies has a one year low of $0.56 and a one year high of $1.30. The firm has a market cap of $23.92 million, a price-to-earnings ratio of -1.48 and a beta of 1.96.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Retractable Technologies stock. Wealthfront Advisers LLC acquired a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned approximately 8.46% of Retractable Technologies at the end of the most recent reporting period. 7.58% of the stock is owned by institutional investors and hedge funds.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.